Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

PubWeight™: 1.06‹?› | Rank: Top 10%

🔗 View Article (PMC 2649503)

Published in PLoS One on March 06, 2009

Authors

Patrick A M Jansen1, Diana Rodijk-Olthuis, Edward J Hollox, Marijke Kamsteeg, Geuranne S Tjabringa, Gys J de Jongh, Ivonne M J J van Vlijmen-Willems, Judith G M Bergboer, Michelle M van Rossum, Elke M G J de Jong, Martin den Heijer, Andrea W M Evers, Mieke Bergers, John A L Armour, Patrick L J M Zeeuwen, Joost Schalkwijk

Author Affiliations

1: Department of Dermatology and Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Articles citing this

A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum Mutat (2011) 1.21

Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease. PLoS One (2009) 1.01

Human gene copy number variation and infectious disease. Hum Genet (2014) 0.97

CCR6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets (2010) 0.88

Copy Number Variation within Human β-Defensin Gene Cluster Influences Progression to AIDS in the Multicenter AIDS Cohort Study. J AIDS Clin Res (2012) 0.83

Nail Psoriasis: A Review of Treatment Options. Drugs (2016) 0.82

The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis. J Immunol Res (2014) 0.81

An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Front Immunol (2015) 0.80

Low DEFB4 copy number and high systemic hBD-2 and IL-22 levels are associated with dermatophytosis. J Invest Dermatol (2014) 0.80

Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children. PLoS One (2014) 0.79

Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation. J Transl Med (2012) 0.79

Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol (2015) 0.79

Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data. BMC Genomics (2015) 0.77

Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study. J Neurol (2016) 0.77

Angiogenesis QTL on Mouse Chromosome 8 Colocalizes with Differential β-Defensin Expression. J Biomol Tech (2015) 0.75

Association of Higher Defensin β-4 Genomic Copy Numbers with Behçet's Disease in Iraqi Patients. Sultan Qaboos Univ Med J (2015) 0.75

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open (2017) 0.75

AMPK/HuR-Driven IL-20 Post-Transcriptional Regulation in Psoriatic Skin. J Invest Dermatol (2015) 0.75

Neutrophil extracellular trap formation is increased in psoriasis and induces human β-defensin-2 production in epidermal keratinocytes. Sci Rep (2016) 0.75

Human β-Defensin 2 in Primary Sclerosing Cholangitis. Clin Transl Gastroenterol (2017) 0.75

Human β-defensin 3 increases the TLR9-dependent response to bacterial DNA. Eur J Immunol (2017) 0.75

Psoriasis-associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. J Invest Dermatol (2017) 0.75

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet (2006) 9.56

Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature (2007) 8.88

Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet (2007) 8.07

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86

A peptide antibiotic from human skin. Nature (1997) 7.64

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93

A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet (2006) 5.10

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science (2002) 4.45

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet (2006) 4.22

Atopic dermatitis. Lancet (2003) 4.14

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med (2005) 4.04

Disease concomitance in psoriasis. J Am Acad Dermatol (1995) 3.92

Mammalian defensins in immunity: more than just microbicidal. Trends Immunol (2002) 3.52

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41

Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet (2003) 3.27

Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol (2005) 2.83

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet (2007) 2.78

Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet (2005) 2.71

Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res (2006) 2.64

The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol (2004) 2.44

Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32

Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol (2003) 2.21

Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol (2002) 2.17

The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology (2005) 1.99

Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology (2004) 1.96

High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol (2005) 1.78

Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol (2005) 1.78

Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol (2002) 1.71

Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48

Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol (2007) 1.46

Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol (2007) 1.42

Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol (2006) 1.40

The cytokine and chemokine network in psoriasis. Clin Dermatol (2007) 1.31

How does one assess early rheumatoid arthritis in daily clinical practice? Best Pract Res Clin Rheumatol (2001) 1.22

Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol (2002) 1.19

Antimicrobial peptides in human skin. Chem Immunol Allergy (2005) 1.15

The concentration dependence of the diffusion coefficient for bovine pancreatic trypsin inhibitor: a dynamic light scattering study of a small protein. Biopolymers (1989) 1.10

Development and validation of human psoriatic skin equivalents. Am J Pathol (2008) 1.09

Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis (1981) 1.03

Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol (1995) 1.02

Differential expression of SKALP/Elafin in human epidermal tumors. Am J Pathol (1993) 1.01

Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS One (2008) 0.87

Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. J Invest Dermatol (1995) 0.86

Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br J Dermatol (2008) 0.85

Articles by these authors

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Many sequence variants affecting diversity of adult human height. Nat Genet (2008) 12.80

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48

Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet (2007) 8.07

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93

New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med (2013) 3.81

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

A common mutation in the defensin DEFB126 causes impaired sperm function and subfertility. Sci Transl Med (2011) 3.13

Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med (2012) 2.91

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res (2006) 2.64

Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet (2005) 2.47

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37

Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30

Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol (2009) 2.26

Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res (Hoboken) (2010) 2.24

Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain (2011) 2.17

Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2007) 2.06

Compound heterozygous mutations of the TNXB gene cause primary myopathy. Neuromuscul Disord (2013) 2.01

Genomic copy number variation, human health, and disease. Lancet (2009) 1.99

Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost (2005) 1.95

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther (2005) 1.85

Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J (2006) 1.84

Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol (2010) 1.82

Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum Mol Genet (2010) 1.82

Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet (2012) 1.81

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79

Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79

Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg (2012) 1.78

High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol (2005) 1.78

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis. Arch Dermatol (2010) 1.77

Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels. Eur J Hum Genet (2006) 1.74

Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet (2009) 1.73

Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72

Experimental aspects of copy number variant assays at CCL3L1. Nat Med (2009) 1.71

Current and future treatment options for acne. J Dermatolog Treat (2006) 1.60

Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol (2004) 1.58

Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet (2010) 1.57

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis. J Negat Results Biomed (2005) 1.55

Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res (2003) 1.52

Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis (2007) 1.46

Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials (2006) 1.44

A systematic review of bio-psychosocial risk factors for an unfavourable outcome after lumbar disc surgery. Eur Spine J (2005) 1.38

A patient's perspective on multidisciplinary treatment gain for fibromyalgia: an indicator for pre-post treatment effects? Arthritis Rheum (2009) 1.38

Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res (2005) 1.36

Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res (2008) 1.35

Allelic recombination between distinct genomic locations generates copy number diversity in human beta-defensins. Proc Natl Acad Sci U S A (2009) 1.33

Skin diseases in family medicine: prevalence and health care use. Ann Fam Med (2008) 1.31

Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res (2011) 1.29

Multiplex Paralogue Ratio Tests for accurate measurement of multiallelic CNVs. Genomics (2008) 1.28

Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. J Invest Dermatol (2009) 1.26

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet (2011) 1.26

Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet (2003) 1.26

Pain-coping strategies in chronic pain patients: psychometric characteristics of the pain-coping inventory (PCI). Int J Behav Med (2003) 1.25

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res (2009) 1.24

Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest (2013) 1.23

Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol Genomics (2005) 1.23

Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet (2010) 1.22

A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum Mutat (2011) 1.21

Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res (2004) 1.20

Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging. Proc Natl Acad Sci U S A (2011) 1.19

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum (2011) 1.18

A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet (2013) 1.17

Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet (2005) 1.16

Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol (2012) 1.15

Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genet (2012) 1.14

Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. Arthritis Rheum (2004) 1.13

Determination of beta-defensin genomic copy number in different populations: a comparison of three methods. PLoS One (2011) 1.12

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet (2013) 1.12